Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avita Medical (AVMXY)

Avita Medical (AVMXY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 651,880
  • Shares Outstanding, K 82,621
  • Annual Sales, $ 5,510 K
  • Annual Income, $ -24,750 K
  • 60-Month Beta 1.28
  • Price/Sales 108.39
  • Price/Cash Flow N/A
  • Price/Book 29.98
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/19/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.9500 +32.61%
on 09/03/19
8.5800 -8.04%
on 09/19/19
+1.9300 (+32.38%)
since 08/30/19
3-Month
4.5100 +74.94%
on 08/05/19
8.5800 -8.04%
on 09/19/19
+1.7000 (+27.46%)
since 06/28/19
52-Week
1.0600 +644.34%
on 12/24/18
8.5800 -8.04%
on 09/19/19
+6.2660 (+385.84%)
since 09/28/18

Most Recent Stories

More News
Dermatology Diagnostic Devices Market Research Report- Opportunities & Challenges With Completely Different Segments, Forecast- 2026

The Global is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers lasers, RF devices, microdermabrasion devices, others. Based on application...

AVMXY : 7.8900 (+9.13%)
CYNO : 66.15 (+0.23%)
SFOSF : 4.0900 (+15.21%)
VRX.TO : 30.80 (-3.33%)
Dermatology Devices Market Research Projection By Trends, Sales, Predicted Revenue, Outlook Analysis & Forecast To 2026

The Global is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers lasers, RF Devices, Microdermabrasion devices, others. Based on application...

AVMXY : 7.8900 (+9.13%)
CYNO : 66.15 (+0.23%)
SFOSF : 4.0900 (+15.21%)
VRX.TO : 30.80 (-3.33%)
Keloid Treatment Market Future Demand Status, Global Industry Revenue of Top Key Players, Industry Share and Manufacturing Size | COVID-19 Impact Forecast by 2020-2027

The global keloid treatment market is expected to reach USD 3.9 billion by 2023 and is expected to increase at a CAGR of 3.5 % during the forecast period from 2018 to 2023.

AVMXY : 7.8900 (+9.13%)
BMY : 57.89 (+0.24%)
NVS : 87.47 (+1.61%)
PRGO : 56.25 (+1.30%)
SRTSU : 6.45 (-0.77%)
SNOA : 6.77 (+0.74%)
VRX.TO : 30.80 (-3.33%)
Dermatology Diagnostic Devices Market Size, Share, Application With Growth & Business Ways Forecast To 2026

The Global is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers lasers, RF devices, microdermabrasion devices, others. Based on application...

AVMXY : 7.8900 (+9.13%)
CYNO : 66.15 (+0.23%)
SFOSF : 4.0900 (+15.21%)
VRX.TO : 30.80 (-3.33%)
Dermatology Devices Market Size, Share, Application With Growth & Business Ways Forecast To 2026

The Global is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers lasers, RF Devices, Microdermabrasion devices, others. Based on application...

AVMXY : 7.8900 (+9.13%)
CYNO : 66.15 (+0.23%)
SFOSF : 4.0900 (+15.21%)
VRX.TO : 30.80 (-3.33%)
AVITA Medical Limited Implementation of the Scheme of Arrangement to Redomicile from Australia to the United States of America

AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that the scheme of arrangement to effect the redomiciliation of the Company and its subsidiaries (Avita Group) from Australia to the...

AVMXY : 7.8900 (+9.13%)
AVITA Medical Limited Proposed Redomiciliation to the United States of America - Court Approves Scheme of Arrangement

AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that the Federal Court of Australia (Court) has today approved the scheme of arrangement to effect a redomiciliation of the Company...

AVMXY : 7.8900 (+9.13%)
AVITA Medical Limited Proposed Redomiciliation to the United States of America - Results of Scheme Meeting

AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that shareholders today voted in favour of the scheme of arrangement to effect a redomiciliation of the Company and its subsidiaries...

AVMXY : 7.8900 (+9.13%)
AVITA Medical Limited Proposed Redomiciliation to the United States of America - Chair's Address to Scheme Meeting

In accordance with ASX Listing Rule 3.13.3, AVITA Medical Limited ACN 058 466 523 (Company) is pleased to provide a copy of the Chair's address for the Scheme Meeting being held virtually at 9.00am (AEST)...

AVMXY : 7.8900 (+9.13%)
Dermatology Devices Market Analysis as per the Latest COVID-19 Impact

AVMXY : 7.8900 (+9.13%)
CYNO : 66.15 (+0.23%)
SFOSF : 4.0900 (+15.21%)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AVMXY with:

Key Turning Points

2nd Resistance Point 8.1433
1st Resistance Point 8.0167
Last Price 7.8900
1st Support Level 7.7967
2nd Support Level 7.7033

See More

52-Week High 8.5800
Last Price 7.8900
Fibonacci 61.8% 5.7074
Fibonacci 50% 4.8200
Fibonacci 38.2% 3.9326
52-Week Low 1.0600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar